CHNUF yields 2000000.00% · PFE yields 6.13%● Live data
📍 CHNUF pulled ahead of the other in Year 1
Combined, CHNUF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CHNUF + PFE for your $10,000?
China Education Resources Inc., an ed-tech company, provides education resources and services for teachers, students, parents, education professionals, and school administrators in the People's Republic of China and China. The company provides systems and contents for online/offline learning, training courses, and social media. It operates an education services portal, cersp.com that provides education resources and services to China's kindergarten to grade 12 education market. The company's portal offers school platform that provides a link between a school with its teachers, students, and parents; online tutoring program, a platform developed for a teacher to provide online tutoring services through the internet to students; and digital education products containing digital textbook tutorial materials and digital supplementary materials, such as lesson plans, course modules, and tests. It also develops and distributes educational textbooks and materials to bookstores and schools. The company was founded in 1997 and is headquartered in Vancouver, Canada.
Full CHNUF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.